stockportfolio.pro
Supernus Pharmaceuticals, Inc. Gross Profit 2010–2025
Supernus Pharmaceuticals, Inc. (SUPN) annual gross profit by fiscal year, computed from SEC filings. Compound growth +31.2%/yr over 15 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $644.39M | 89.6% | +10.4% |
| FY 2024 | $583.91M | 88.2% | +11.5% |
| FY 2023 | $523.74M | 86.2% | -9.7% |
| FY 2022 | $580.02M | 86.9% | — |
| FY 2021 | — | — | — |
| FY 2020 | $467.94M | 89.9% | +24.4% |
| FY 2019 | $376.10M | 95.8% | -4.4% |
| FY 2018 | $393.54M | 96.2% | +37.1% |
| FY 2017 | $287.02M | 95.0% | +41.4% |
| FY 2016 | $203.02M | 94.4% | +46.0% |
| FY 2015 | $139.04M | 94.3% | +60.0% |
| FY 2014 | $86.92M | 93.8% | +696.3% |
| FY 2013 | $10.91M | 90.8% | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
| FY 2010 | — | — | — |
Source: Supernus Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Supernus Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSupernus Pharmaceuticals, Inc. — frequently asked questions
What is Supernus Pharmaceuticals, Inc.'s gross profit?
Supernus Pharmaceuticals, Inc. (SUPN) reported gross profit of $644.39M for fiscal year 2025, per its SEC filings.
How has Supernus Pharmaceuticals, Inc.'s gross profit changed over time?
Between fiscal 2010 and 2025, SUPN's gross profit grew at roughly 31.2% per year (compound annual rate), from $10.91M to $644.39M.
Where does this data come from?
Figures are computed from Supernus Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.